Opening https://www.businesswire.com/news/home/20230314005733/en/Aldeyra-Therapeutics-Announces-Completion-of-Enrollment-in-Phase-2-Clinical-Trial-of-ADX%E2%80%912191-in-Retinitis-Pigmentosa